Newsbot
Trump plans U.S. control of Venezuelan oil for years to come, targeting $50/bbl - WSJ
Defensive Stocks Rotation Ahead Of NFP - Index Outlook And NFP Trading Levels
Soren Acquisition Corp. Announces Closing of $253 Million Initial Public Offering
Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.
JCPenney is selling a $142 farmhouse comforter set for just $39
Shoppers say its "so soft and comfortable."
NYT Pips Today: Hints, Answers And Full Solution For Friday, January 9
Looking for help with todays New York Times Pips? Well walk you through todays puzzle and help you match dominoes to tiles.
EICC: Attractive CEF Liabilities After The Refinancing
WD-40 Company (WDFC) Q1 2026 Earnings Call Transcript
Why Costco Stock Popped Today
The retail titans sales are growing at an impressive clip.
Kinaxis ernennt Razat Gaurav zum neuen CEO
OTTAWA, Ontario, Kanada--(BUSINESS WIRE)--Kinaxis® Inc. (TSX:KXS), ein weltweit führender Anbieter im Bereich der Supply-Chain-Orchestrierung, gab heute die Ernennung von Herrn Razat Gaurav zum Chief Executive Officer (CEO) mit Wirkung zum 12. Januar 2026 bekannt. Zu seinem offiziellen Amtsantritt wird er außerdem Mitglied des Board of Directors von Kinaxis. „Nach einer intensiven Suche hat sich das Board für Razat als neuen CEO entschieden“, erklärt Bob Courteau, Interim-CEO und Board Chair be
Tim Burchett Reacts To Senate Advancing Venezuela War Powers Resolution
Rep. Burchett discussed on "Forbes Newsroom" the Senate advancing a bipartisan war powers resolution that would block Trump from further military action in Venezuela.
Lucid Doubled Its Vehicle Production in 2025. Its Still Not Time to Buy the Stock.
Lucids vehicle production increase is impressive, but the company is burning through cash and doesnt have a clear path for success.
Apple: Time To Get Out
Outsized Gains: Factors That Determine Stock Outperformance
When it comes to outperformance, several factors, including robust sales growth, margin expansion, innovation, and favorable earnings estimate revisions, are all contributing factors.
NYT Strands Hints, Spangram, Answers: Friday, January 9 (For Cubs Fans)
Looking for help with todays NYT Strands puzzle? Heres an extra hint to help you uncover the right words, as well as all of todays answers and Spangram.
Jack Henry & Associates: Reliable Compounder, Solid Outlook
Enterprise Products Up 6% in a Year: Time to Bet on the Stock or Wait?
EPD beat its industry with a 6% yearly gain, backed by inflation-linked contracts and capital returns, but valuation and leverage argue for patience.
Best Income Stocks to Buy for January 9th
ACRE, STEP and ADEA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 9th, 2026.
Looking for a Growth Stock? 3 Reasons Why Commercial Metals (CMC) is a Solid Choice
Commercial Metals (CMC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Best Growth Stocks to Buy for January 9th
CIEN and CMC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 9th, 2026.
Salesforce Plunges 20% in a Year: Is CRM Stock Still a Hold?
CRM shares are down 18% in a year, but AI momentum, enterprise expansion and discounted valuation suggest Salesforce may still be worth holding.
Bear of the Day: JD.com (JD)
Between alarming slowdowns in growth and the financial strain of expansion into the competitive food delivery market, JDs "cheap" share price may be warranted.
Will Accelerating AWS Revenue Growth Drive AMZN Stocks 2026 Rally?
Amazons AWS posts its fastest growth since 2022 as AI demand surges, with a $200 billion backlog and heavy investment fueling 2026 optimism.
3 MedTech Stocks That Crushed the S&P 500 Over the Past Year
TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.
Goldman Projects 46-Cent EPS Gain in Q4 From Apple Card Transition
GS expects a 46-cent EPS boost in 4Q25 as it exits the Apple Card, releasing reserves amid a 24-month transition of the program to JPMorgan.
Heres What We Expect From AbbVies Immunology Segment in Q4
ABBVs Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humiras past loss of exclusivity.
XOMs Integrated Business Model Shields Earnings Amid Lower Oil Prices
ExxonMobil warns that upstream earnings face pressure from lower oil prices, but its integrated model boosts refining gains to cushion profitability.
The S&P 500 Is Expected to Rally 12% This Year
Goldman Sachs Research predicts US stocks will rally again in 2026 amid solid economic growth and continued easing from the Fed.
UBER vs. BIDU: Which Stock Is Better Placed in the Promising AV Space?
Baidu edges ahead of Uber in the AV race, backed by global robotaxi rollout, stronger earnings outlook and valuation.
3 Oil Stocks to Start 2026: Values or Traps?
With Venezuelan oil back in the spotlight, should you buy Exxon, Chevron or ConocoPhillips?
ADI Climbs 35.7% in a Year: Should You Buy, Sell or Hold the Stock?
Analog Devices shares surge 35.7% in a year as AI-driven demand lifts industrial and communications growth, boosts data center sales and supports strong margins.
SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales
Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support confidence for the rest of fiscal 2026.
BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock?
BMY shares have surged in the past six months, driven by Opdivo, Reblozyl and a guidance raise, as growth drugs offset mounting generic pressure
3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns in 2026
Broker upgrades make TripAdvisor, Marathon Petroleum and J.B. Hunt Transport top picks for 2026, with strong earnings growth on the horizon.
New Strong Buy Stocks for January 9th
BDTX, LUMN, ADEA, ACRE and TACT have been added to the Zacks Rank #1 (Strong Buy) List on January 9th, 2026.
HELE Q3 Earnings Meet Estimates, Home & Outdoor Sales Decline Y/Y
HELEs third-quarter earnings meet estimates as sales decline year over year, with Home & Outdoor weakness partly offset by Olive & June growth.
3 Construction & Mining Equipment Stocks to Watch Despite Industry Headwinds
The Zacks Industry Rank for the Manufacturing - Construction and Mining industry paints a dull picture. We believe that stocks like CAT, TEX and ASTE are still worth a look.
JPM Q4 Earnings on Deck: Buy, Sell or Hold the Stock Ahead of Results?
JPMorgans Q4 earnings preview shows strength in trading and lending, but expenses and valuation may weigh on investor sentiment.
V.F. (VFC) Stock Sinks As Market Gains: What You Should Know
V.F. (VFC) concluded the recent trading session at $19.86, signifying a -1.63% move from its prior days close.
The Stock-Market Rally Isn’t Just About Tech Anymore
Hopes for an economic reacceleration are helping to fuel a “rotation trade.”
Oil Services ETF (OIH) Hits New 52-Week High
OIH hits a fresh 52-week high as oil prices stay firm and momentum builds. Can the rally last amid high risk?
Where to Find Opportunities in AI Stocks at the Start of 2026
AI stocks flew high in 2025 despite year-end volatility. Palantir and Lam look overvalued, but opportunities remain.
Micron vs. NVIDIA: One AI Chip Stock is Poised to Win Big in 2026
Micron surged past Nvidia last year as AI-driven HBM chip demand lifted revenue and profits. Can it keep the edge in 2026 as Nvidia scales Blackwell?
Bull of the Day: Eli Lilly (LLY)
Eli Lilly has solidified itself as a global pharma titan. With leading drugs and a massive obesity market, Lilly is poised to be a juggernaut for years to come.
Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond
After a late-2025 rebound eased policy fears, healthcare ETFs like IXJ are gaining attention as investors position for a sector comeback in 2026.
Verizon Outpaces Its Industry in a Year: How to Play the Stock?
VZ has outpaced its wireless industry over the past year as 5G upgrades, network slicing and new partnerships fuel growth despite debt and competition.
Ondas Up Nearly 600% in the Past Six Months: How to Play the Stock?
ONDS has surged nearly 600% in six months as it pivots to autonomous systems, but soaring costs and valuation raise exit questions.
Why History Says We Could See the Nasdaq Double
Stocks have staged a remarkable rally since the Liberation Day lows, and Andrew Rocco believes the bull market still has plenty of room to run. Discover how the 1999 internet boom can help you capitalize on this powerful trend in 2026 and beyond.
Best Value Stocks to Buy for January 9th
ACRE made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 9th, 2026.
4 Top-Ranked Tech Stocks to Buy as Semiconductor Rally Continues
Semiconductor sales hit a record in November, with NVDA, MU, CRDO and ASYS set to gain from booming AI demand.
Merck in Talks to Buy Revolution Medicines Per Financial Times Report
Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.
3 Medical Service Industry Stocks Set to Tackle Workforce Challenges
Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.
Broad EPS Strength Lifts: Zacks JAN 2026 Market Strategy
Liquidity catalysts will be debated for 2026, from both global (U.S. and non-U.S.) monetary authorities. It is not guaranteed to work for stocks like it did in 2025.
Can Strong Earnings Justify High Stock Valuations?
With the 2025 Q4 earnings season about to begin, we discuss how critical the overall earnings picture is to the stock market.
Kratos Defense Stock Rises 35.3% in a Month: Heres How to Play
KTOS has jumped 35.3% in a month on contract wins and rising unmanned system demand, but weaker ROIC and sector risks complicate the entry timing.
Salesforce Plunges 20% in a Year: Is the CRM Stock Still a Hold?
CRM shares are down 18% in a year, but AI momentum, enterprise expansion and discounted valuation suggest Salesforce may still be worth holding.
Bed Bath & Beyond (BBBY) Surges 12.2%: Is This an Indication of Further Gains?
Bed Bath & Beyond (BBBY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Gold Steadies as Mixed US Data Dims Fed Rate-Cut Bets This Month
Gold steadied as traders maintained expectations that the Federal Reserve will hold rates steady at their January meeting, after key US jobs data gave mixed signals about the health of the US economy.
NASA to bring Space Station astronauts back to Earth weeks early due to medical situation
NASA earlier delayed a planned spacewalk with ISS Commander Mike Fincke and flight engineer Zena Cardman.
Lumos Diagnostics Holdings Limited (LDXHF) Shareholder/Analyst Call Transcript
Trump Has ‘No Plan’ For Venezuela After Maduros Capture: Debbie Wasserman Schultz
Rep. Debbie Wasserman Schultz (D-FL) joined "Forbes Newsroom" to discuss whats next following the capture of Venezuelan President Nicolás Maduro by U.S. forces.
Why Tilray Brands Stock Is Rising in After-Hours Trading
Tilray had good things to say about its recent quarter -- and investors were listening.
Job Openings Fall To 14-Month Low
Booz Allen Hamilton: A Much More Constructive Environment In 2026
Jim Cramer says the market rotation is punishing last year’s winners and reviving beaten-down stocks
Jim Cramer said investors are witnessing a classic market rotation, as capital flows from last year’s biggest winners into stocks that had fallen out of favor.
3 Millionaire-Maker Artificial Intelligence (AI) Stocks
You dont have to buy risky stocks to invest in the AI boom.
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility
Ukraine Awards Major Lithium Project to Investors With Links to Trump
Ronald S. Lauder, a billionaire friend of Mr. Trump, is among the investors. The move comes as the Trump administration looks to profit from investment opportunities in Ukraine.
Wall Street strategist reveals game plan for 2026
Sam Stovall has been navigating stocks for a long time. Stovall is the Chief Investment Strategist at CFRA, and his stock market experience is rooted in over 30 years of tracking markets, dating back to his tenure as managing director and chief investment strategist at S&P Global and ...
IRW-News: Lir Life Sciences Corp.: LIR Life engagiert Neuland Labs, um die Entwicklung zelldurchdringender Peptide für die transdermale GLP-1/GIP-Plattform voranzutreiben
IRW-PRESS: Lir Life Sciences Corp.: LIR Life engagiert Neuland Labs, um die Entwicklung zelldurchdringender Peptide für die transdermale GLP-1/GIP-Plattform voranzutreibenVancouver, Kanada - 8. Januar 2026 / IRW-Press / LIR Life Sciences Corp. (CSE: ...
Countries and industries most exposed to Trumps IEEPA-based tariffs
The U.S. Supreme Court is set to issue rulings on Friday on cases related to the legality of tariffs imposed by President Donald Trump under the International Emergency Economic Powers Act.
Oil Holds Biggest Gain Since October as Iran Protests Escalate
Oil held onto its biggest daily gain since October, as Iran attempted to quell escalating protests and President Donald Trump threatened repercussions if demonstrators were targeted.
California Water Service Group Expanding Investment and Operations in Texas
California Water Service Group Expanding Investment and Operations in Texas